相关实验视频
Updated: May 22, 2025

06:09
An In Ovo Model for Testing Insulin-mimetic Compounds
Published on: April 23, 2018
9.8K
关于当前2型糖尿病 (T2DM) 药物可用目标和针对它们的药物的最新情况
Prerna Uniyal1, Surbhi Panwar1, Akanksha Bhatt1
1School of Pharmacy, Graphic Era Hill University, Bell Road, Clement Town, Dehradun, Uttarakhand, India.
Molecular diversity
|March 13, 2025
概括
2型糖尿病 (T2DM) 的管理是具有挑战性的. 本综述探讨了新的药物标和疗法,包括组合治疗,以对抗高血糖及其并发症.
科学领域:
- 内分泌学和新陈代谢学
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 2型糖尿病 (T2DM) 是一种全球性健康问题,其特点是高血糖,导致严重的并发症,如中风和器官损伤.
- 尽管取得了进展,但有效管理T2DM仍然是一个重大挑战,推动了寻找新型治疗策略的研究.
- 开发新的抗糖尿病药物需要识别新的标蛋白及其调节剂.
研究的目的:
- 审查2型糖尿病管理的最新进展.
- 整合关于新型标蛋白,它们的抑制剂和T2DM临床药物的信息.
- 根据它们的目标对抗糖尿病药物进行分类:传统药物,目前正在探索的药物和新兴药物.
主要方法:
- 对T2DM管理的最新进展进行了全面的文献审查.
- 对单一,双重和三重组合疗法临床数据的分析.
- 检查药物机制,化学结构和目标相互作用.
主要成果:
- 确定T2DM的传统,目前正在探索和新兴药物点.
- 现有和新型抗糖尿病药物的概述,包括它们的作用机制.
- 讨论用于改善T2DM症状管理的组合治疗策略.
结论:
- 该综述提供了关于T2DM药物标和治疗方法的综合资源.
- 了解这些目标和药物对于开发下一代抗糖尿病疗法至关重要.
- 未来的研究应该专注于新兴的目标和用于加强T2DM控制的组合疗法.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
Diabetes Mellitus: Overview and Type I Subtype
2.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.3K
Diabetes: Management and Pharmacotherapy
220
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
220
Glucagon-like Receptor Agonists
281
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
281
Carbohydrate Metabolism
10.7K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
10.7K
Oral Hypoglycemic Agents: Biguanides and Glitazones
148
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
148

